{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:58:19Z","timestamp":1789095499109,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016939","name":"Myriad Genetics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016939","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["5P30CA006973-52"],"award-info":[{"award-number":["5P30CA006973-52"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["W81XWH-20-1-0843"],"award-info":[{"award-number":["W81XWH-20-1-0843"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.humpath.2024.105693","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T16:26:58Z","timestamp":1732033618000},"page":"105693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Genetic validation of a TSC2 immunohistochemistry assay in TSC\/mTOR-pathway altered renal tumors"],"prefix":"10.1016","volume":"154","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8288-0549","authenticated-orcid":false,"given":"Amir","family":"Akbari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarence Rachel","family":"Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Hes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean R.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Kandukuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aggarwal","family":"Aditi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristyna","family":"Pivovarcikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Argani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sambit K.","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushal","family":"Asrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara L.","family":"Lotan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.humpath.2024.105693_bib1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1136\/adc.72.6.471","article-title":"Tuberous sclerosis","volume":"72","author":"Webb","year":"1995","journal-title":"Arch Dis Child"},{"issue":"9639","key":"10.1016\/j.humpath.2024.105693_bib2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"issue":"5327","key":"10.1016\/j.humpath.2024.105693_bib3","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34","volume":"277","author":"van Slegtenhorst","year":"1997","journal-title":"Science"},{"issue":"27","key":"10.1016\/j.humpath.2024.105693_bib4","doi-asserted-by":"crossref","first-page":"16409","DOI":"10.1074\/jbc.270.27.16409","article-title":"Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity","volume":"270","author":"Wienecke","year":"1995","journal-title":"J Biol Chem"},{"issue":"7413","key":"10.1016\/j.humpath.2024.105693_bib5","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nature11310","article-title":"Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice","volume":"488","author":"Tsai","year":"2012","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.humpath.2024.105693_bib6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/gcc.2870130411","article-title":"Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas","volume":"13","author":"Henske","year":"1995","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"10.1016\/j.humpath.2024.105693_bib7","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.humpath.2024.105693_bib8","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/PAS.0000000000000248","article-title":"Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients","volume":"38","author":"Guo","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.humpath.2024.105693_bib9","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/PAS.0000000000000237","article-title":"Renal cell carcinoma in tuberous sclerosis complex","volume":"38","author":"Yang","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.humpath.2024.105693_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/genes12101585","article-title":"Renal cell carcinoma in tuberous sclerosis complex","volume":"12","author":"Henske","year":"2021","journal-title":"Genes"},{"issue":"5","key":"10.1016\/j.humpath.2024.105693_bib11","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/PAS.0000000000001422","article-title":"\"Renal cell carcinoma with leiomyomatous stroma\" harbor somatic mutations of TSC1, TSC2, MTOR, and\/or ELOC (TCEB1): clinicopathologic and molecular characterization of 18 sporadic tumors supports a distinct entity","volume":"44","author":"Shah","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2024.105693_bib12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/PAP.0000000000000337","article-title":"Renal cell carcinoma with fibromyomatous stroma-the whole story","volume":"29","author":"Shah","year":"2022","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2024.105693_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/PAS.0000000000000508","article-title":"Eosinophilic, solid, and cystic renal cell carcinoma: clinicopathologic study of 16 unique, sporadic neoplasms occurring in women","volume":"40","author":"Trpkov","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.humpath.2024.105693_bib14","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/PAS.0000000000000838","article-title":"Eosinophilic solid and cystic renal cell carcinoma (ESC RCC): further morphologic and molecular characterization of ESC RCC as a distinct entity","volume":"41","author":"Trpkov","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.humpath.2024.105693_bib15","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/PAS.0000000000001067","article-title":"Are sporadic eosinophilic solid and cystic renal cell carcinomas characterized by somatic tuberous sclerosis gene mutations?","volume":"42","author":"Parilla","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.humpath.2024.105693_bib16","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/PAS.0000000000001111","article-title":"Eosinophilic solid and cystic (ESC) renal cell carcinomas harbor TSC mutations: molecular analysis supports an expanding clinicopathologic spectrum","volume":"42","author":"Palsgrove","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2024.105693_bib17","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41379-021-00816-8","article-title":"TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study","volume":"35","author":"Munari","year":"2022","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.humpath.2024.105693_bib18","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00428-018-2456-4","article-title":"\"High-grade oncocytic renal tumor\": morphologic, immunohistochemical, and molecular genetic study of 14 cases","volume":"473","author":"He","year":"2018","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1016\/j.humpath.2024.105693_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/PAS.0000000000001170","article-title":"Somatic mutations of TSC2 or MTOR characterize a morphologically distinct subset of sporadic renal cell carcinoma with eosinophilic and vacuolated cytoplasm","volume":"43","author":"Chen","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2024.105693_bib20","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41379-021-00923-6","article-title":"Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC\/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases","volume":"35","author":"Farcas","year":"2022","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.humpath.2024.105693_bib21","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/his.13865","article-title":"Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7-positive): a distinct entity?","volume":"75","author":"Trpkov","year":"2019","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.humpath.2024.105693_bib22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41379-021-00896-6","article-title":"Germline and sporadic mTOR pathway mutations in low-grade oncocytic tumor of the kidney","volume":"35","author":"Kapur","year":"2022","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.humpath.2024.105693_bib23","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/his.14816","article-title":"Low-grade oncocytic tumour of the kidney is characterised by genetic alterations of TSC1, TSC2, MTOR or PIK3CA and consistent GATA3 positivity","volume":"82","author":"Williamson","year":"2023","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.humpath.2024.105693_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41379-021-00969-6","article-title":"Oncocytic renal neoplasms with diffuse keratin 7 immunohistochemistry harbor frequent alterations in the mammalian target of rapamycin pathway","volume":"35","author":"Mohanty","year":"2022","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.humpath.2024.105693_bib25","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1097\/PAS.0000000000001940","article-title":"Xanthomatous giant cell renal cell carcinoma: another morphologic form of TSC -associated renal cell carcinoma","volume":"46","author":"Argani","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.humpath.2024.105693_bib26","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/PAS.0000000000001955","article-title":"TSC\/MTOR -associated eosinophilic renal tumors exhibit a heterogeneous clinicopathologic spectrum : a targeted next-generation sequencing and gene expression profiling study","volume":"46","author":"Xia","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.humpath.2024.105693_bib27","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1158\/1078-0432.CCR-15-2631","article-title":"Mutations in TSC1, TSC2, and MTOR are associated with response to rapalogs in patients with metastatic renal cell carcinoma","volume":"22","author":"Kwiatkowski","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.humpath.2024.105693_bib28","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/path.5875","article-title":"GPNMB expression identifies TSC1\/2\/mTOR-associated and MiT family translocation-driven renal neoplasms","volume":"257","author":"Salles","year":"2022","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2024.105693_bib29","doi-asserted-by":"crossref","first-page":"6808","DOI":"10.1038\/s41467-022-34617-7","article-title":"An mTORC1-mediated negative feedback loop constrains amino acid-induced FLCN-Rag activation in renal cells with TSC2 loss","volume":"13","author":"Asrani","year":"2022","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.humpath.2024.105693_bib30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ccr.2014.07.014","article-title":"The somatic genomic landscape of chromophobe renal cell carcinoma","volume":"26","author":"Davis","year":"2014","journal-title":"Cancer Cell"},{"issue":"7456","key":"10.1016\/j.humpath.2024.105693_bib31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","author":"Cancer Genome Atlas Research","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.humpath.2024.105693_bib32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa1505917","article-title":"Comprehensive molecular characterization of papillary renal-cell carcinoma","volume":"374","author":"Cancer Genome Atlas Research","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.humpath.2024.105693_bib33","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41379-021-00737-6","article-title":"Novel, emerging and provisional renal entities: the Genitourinary Pathology Society (GUPS) update on renal neoplasia","volume":"34","author":"Trpkov","year":"2021","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.humpath.2024.105693_bib34","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/PAS.0000000000001457","article-title":"Eosinophilic renal cell tumors with a TSC and MTOR gene mutations are morphologically and immunohistochemically heterogenous: clinicopathologic and molecular study","volume":"44","author":"Tjota","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2024.105693_bib35","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/his.13395","article-title":"Re-evaluation of 33 'unclassified' eosinophilic renal cell carcinomas in young patients","volume":"72","author":"Li","year":"2018","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.humpath.2024.105693_bib36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/PAP.0000000000000419","article-title":"Renal cell carcinoma associated with TSC\/MTOR genomic alterations: an update on its expanding spectrum and an approach to clinicopathologic work-up","volume":"31","author":"Shah","year":"2024","journal-title":"Adv Anat Pathol"},{"issue":"12","key":"10.1016\/j.humpath.2024.105693_bib37","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.1172\/JCI128287","article-title":"mTORC1 feedback to AKT modulates lysosomal biogenesis through MiT\/TFE regulation","volume":"129","author":"Asrani","year":"2019","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.humpath.2024.105693_bib38","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41467-023-44229-4","article-title":"TFEB drives mTORC1 hyperactivation and kidney disease in Tuberous Sclerosis Complex","volume":"15","author":"Alesi","year":"2024","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.humpath.2024.105693_bib39","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.euf.2015.07.005","article-title":"PTEN loss as determined by clinical-grade immunohistochemistry assay is associated with worse recurrence-free survival in prostate cancer","volume":"2","author":"Lotan","year":"2016","journal-title":"Eur Urol Focus"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817724002028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817724002028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T20:31:10Z","timestamp":1787257870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817724002028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":39,"alternative-id":["S0046817724002028"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2024.105693","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic validation of a TSC2 immunohistochemistry assay in TSC\/mTOR-pathway altered renal tumors","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2024.105693","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105693"}}